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Abstract 
 
The present work aimed at the implementation of a semi-preparative high-
performance liquid chromatography (HPLC) method that allows for the separation of 
two guaianolide-type STLs (compounds 6 and 7) from a mixture of both compounds. 
Moreover, the work comprised the semi-synthesis of new aminoderivatives of these 
compounds with improved bioavailability, due to increased water-solubility and 
lower toxicity while retaining their anti-tumoral activity. Alongside, a preliminary 
screening has been conducted to assess the potential cytotoxicity of one of the STLs 
(compound 3) towards normal, non-neoplastic cells, specifically fibroblasts. 
The complete semi-preparative separation of the two STLs (6 and 7) was not 
accomplished, even though different mobile phase conditions were tested. A high 
load (100 µL) sample of the mixture of 6 and 7 onto the C18 column resulted into a 
decrease in chromatographic resolution due to peak width broadening, which led to a 
significant co-elution of 6 and 7, with retention times of 38.81 min and 39.89 min, 
respectively. 
Furthermore, N, N-dimethylaminogrosshemin-2,3-dihydroxyisobutyrate (6a) 
and N, N-dimethylaminodehydrogrosshemin-2,3-dihydroxyisobutyrate (7a) were 
obtained through a Michael addition of dimethylamine  to the α-methylene-γ-lactone 
ring, more specifically to the electrophilic vinylic carbon C-13, of 6 and 7, 
respectively. The semi-synthesis of the aminoderivatives was confirmed through 
comparison of their 13C NMR and 1H NMR spectra with the complete NMR 
characterization of STLs 6 and 7. 
Finally, the preliminary in vitro cytotoxicity studies of compound 6 on normal 
human fibroblasts indicated, through observation of the cells on an inverted 
fluorescence microscope and percent viability of cells data, that STL 6 is not toxic 
towards normal human foreskin fibroblast cells in concentrations of up to 2.75 μM 
after a period of incubation from 24h – 72h. 
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1. Introduction 
1.1. Review on sesquiterpene lactones 
 
In 1960, as part of an effort to discover naturally occurring anticancer agents, 
the National Cancer Institute (NCI, USA) launched a large-scale screening program 
where 35 000 plant samples were evaluated, from which arose Taxol, the best-selling 
antitumor drug nowadays (Ghantous et al. 2010). Actually, over the last half century 
most plant secondary metabolites and their derivatives have been applied towards 
the treatment of cancer, which totalizes 67% of all anticancer drugs. Furthermore, 
over 200 natural product-derived drugs are in preclinical or clinical development 
(Balunas & Kinghorn 2005; Ghantous et al. 2010; Harvey 2008). Research on the 
natural compounds sesquiterpene lactones (STLs) began within few years of the NCI 
screening program leading to the identification of STLs as one of the most prevalent 
groups of cytotoxic and anti-tumoral compounds from plants (Fernandes et al. 2008; 
Ghantous et al. 2010). 
Sesquiterpene lactones are one of the largest groups of secondary metabolites 
with biological significance that are found in several species across the plant 
kingdom, belonging predominantly to the Asteraceae (or Compositae) family, where 
they can be found at concentrations varying from 0.001% to 8% of plant dry weight 
(Ghantous et al. 2010; Amorim et al. 2013; Chadwick et al. 2013). In its turn, 
Asteraceae is one of the largest family of flowering plants (angiosperms), with over 
23 000 currently recognized species spread across 1 620 genera and 12 subfamilies 
being distributed worldwide, occurring in every continent except Antarctica and 
prospering in any habitat compatible with the development of vascularity (Bohm & 
Stuessy 2001; Cronquist 2001; Amorim et al. 2013). 
STLs are typically located in laticifers, which are plant specialized cells that 
have a secretory nature (Chadwick et al. 2013). Laticifers serve as a repository for 
natural products, including proteins and other metabolites present in latex, which 
have been shown to protect plants against feeding insects, herbivores and that are 
also beneficial for humans (Hagel et al. 2008). 
In fact, in most of the Asteraceae, STLs act as communication substances that 
help organisms to cope with each other and as a defence mechanism against 
predation (Amorim et al. 2013). These compounds are emitted, among a wide range 
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of different compounds, by plants during the biogenic volatile organic compound 
(BVOC) response (Chadwick et al. 2013), although they constitute a low percentage 
of BVOCs due to their low volatility (Tschiggerl & Bucar 2012). BVOCs not only 
constitute a platform for plant-plant interactions, prompting nearby plants’ defence 
mechanisms against insects and other predators, but can also be toxic to insects. 
Their potential as anti-feedants is also due to their bitterness which repels chewing 
insects and birds that disrupt cells when feeding (Chadwick et al. 2013; Kegge & 
Pierik 2010). 
Allelopathic function is also verified in sesquiterpene lactones exuded into the 
rhizosphere (Chadwick et al. 2013) - a biologically active and densely populated soil 
zone (Walker et al. 2003) - through the roots, in the form of BVOCs. This involves 
offensive strategies that inhibit the performance of proximate competitors, for 
instance many sesquiterpene lactones from sunflowers reduce the germination rates 
of plants from other families (like Solanaceae) to reduce competition in the area 
(Chadwick et al. 2013; Kegge & Pierik 2010). 
Likewise, there is evidence of an antimicrobial function in which the polar 
groups present in STLs disrupt the phospholipid membrane of microorganisms 
preventing their attack (Chadwick et al. 2013). 
Human populations are mainly exposed to STLs through their use as herbal 
remedies, as part of a western diet – STLs of the guaianolide class, such as lactucin, 
lactucopicrin, and 8-deoxylactucopicrin are found in lettuce (Lactuca sativa) 
(Chadwick et al. 2013) – and as therapeutic drugs (Amorim et al. 2013). However, 
exposure to STLs in their natural habitats can cause adverse effects due to direct 
contact with plants rich in STL allergens, such as parthenin, helenalin, helenin and 
hymenin, which are manifested as allergic contact dermatitis (Ghantous et al. 2010; 
Salapovic et al. 2013). 
The main interest in sesquiterpene lactones for health benefit purposes is 
related to their anti-tumoral potential, since some of the STLs have been found to 
show enough potential to enter clinical trials. Nevertheless, there is a wide variety of 
other pharmacological applications of STLs, including anti-inflammatory, anti-
bacterial, anti-fungal, anti-viral, anti-protozoal, anti-helminthic, anti-ulcer, 
molluscicidal, hepatoprotective and hepatocurative, anti-depressant, anti-malarial, 
anti-migraine, analgesic and sedative. They are also considered in the treatment of 
cardiovascular diseases, prevention of neurodegeneration, and treatment of mild 
illnesses such as diarrhoea, flu, and burns. The cardiovascular effects are attributed 
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to their ability to relax smooth muscle tissue by inhibiting the nuclear factor-kB (NF-
κB), which in its turn inhibits the inducible form of nitric oxide synthase (iNOS) up-
regulation, and consequently increases levels of NO (Amorim et al. 2013; Chadwick et 
al. 2013; Ghantous et al. 2010). 
STLs are a colourless, bitter and stable subfamily of terpenoids of lipophilic 
character composed of a 15-carbons (C15) backbone that contains a lactone group 
(Ghantous et al. 2010). There were over 5000 different members of the STL family in 
2000, a number which continued growing since then, as covered in the reviews on 
natural sesquiterpenoids by Fraga every year (Fraga 2013). Thus, they are very 
diverse in terms of their structure, properties, and proposed functions (Chadwick et 
al. 2013). Generally, considering their carbocyclic skeleton, they can be divided into 
the following major groups, which are generally represented in Figure 1: 
germacranolides (a) (ten-membered ring); eudesmanolides (b) and eremophilanolides 
(c) (all 6/6-bicyclic compounds); and guaianolides (d) and pseudoguaianolides (e) (all 
5/7-bicyclic compounds) (Amorim et al. 2013; Ghantous et al. 2010). All STLs are 
derived from farnesyl diphosphate (FPP) through cyclization and oxidative 
transformation yielding, for instance, costunolide (1), the common precursor for 
germacranolides, eudesmanolides and guaianolides (Eljounaidi et al. 2014). 
Furthermore, they all contain a fused 5-membered lactone group (γ-lactone) and 
they mostly have one methylene group at the alpha position to the carbonyl group 
(Fraga 2013). 
 
 
Figure 1. Chemical structures of different subgroups of sesquiterpene lactones. (a) Germacranolide; 
(b) eudesmanolide; (c) eremophilanolide; (d) guaianolide; (e) pseudoguaianolide. 
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STLs’ biological activity is mainly due to an alkylation mechanism by which 
they covalently bond with biological macromolecules. Thus, alkylating centre 
reactivity influences their activity, with the major alkylating centres being the α-
methylene-γ-lactone, α-methylene-δ-lactone, δ,β-cyclopentenones and side chain 
unsaturated esters (Amorim et al. 2013; Ghantous et al. 2010). 
The α-methylene-γ-lactone group (αMγL), an oxygen-containing ring structure 
with a carbonyl function, is viewed as essential for STLs’ biological effects, with 
other functional groups in the structure merely modifying the ring’s potency by steric 
and chemical influences. Moreover, the αMγL unit exerts its therapeutic influence by 
means of alkylation of thiol groups commonly found in its molecular targets. It reacts 
with biological nucleophiles by Michael-type addition of free cysteine sulphydril (-SH) 
groups (typically residues in proteins), therefore, forming stable adducts (Figure 2). 
Consequently, they cause alteration of gene expression, by inhibiting enzymes 
involved in biological processes, with the effect of sensitizing cancer (Chadwick et 
al. 2013; Fernandes et al. 2008; Foster et al. 2011; Rivero et al. 2003; Scotti et al. 
2007). 
 
 
Figure 2. Michael addition of thiols to the α-methylene-γ-lactone of sesquiterpene lactones. 
 
However, the unspecific, non-selective nature of this action causes STLs to 
bind to blood proteins containing sulfhydryl groups, reducing their bioavailability and 
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preventing them from achieving concentrations that are crucial to cytotoxicity 
(Amorim et al. 2013; Ghantous et al. 2010). 
The presence of a side chain and/or the level of lipophilicity can also affect 
the activity of these compounds. On the one hand, higher lipophilicity may facilitate 
penetration through the cytoplasmic membrane, by this means increasing STLs 
cytotoxicity in vitro, causing them, in return, to be less bioavailable in vivo. On the 
other hand, a side chain ester, in compounds having the α-methylene-γ-lactone as 
the only alkylating centre, increases cytotoxicity regardless of its lipophilic 
properties although in the presence of two alkylating centres, an ester side chain has 
to be lipophilic and conjugated to increase STL power. Moreover, it was verified that 
the presence, in an proper site, of an OH group enhanced STL bioactivity while 
decreasing lipophilicity (Ghantous et al. 2010). 
Molecular geometry and electronic features also plays an important role in 
STL cytotoxicity. The guaianolides and the pseudoguaianolides are the most active 
compounds owing to the double bond in the five-membered ring at C-3, as well as to 
a methylene at C-10, present in the most potent STLs within these two families 
(Fernandes et al. 2008; Ghantous et al. 2010). 
STLs biochemical mechanisms for selectively targeting cancer cells have been 
object of systematic study for several years now. As a result several of these 
compounds, including a parthenolide (PTL, 2) derivative – dimethylamino- 
parthenolide (DMAPT, 2a) –, two artemisinin derivatives – artesunate (3) and 
artemether (4) – and thapsigargin (5), are now in cancer clinical trials (Table 1; 
Figure 3). Their selectivity to target tumor and cancer stem cells while sparing 
normal ones is attributed to their ability to target the sarco/endoplasmic reticulum 
calcium ATPase (SERCA) pump, particular proteases secreted by cancer cells, high 
iron content and cell surface transferrin receptors, NF-kB signaling pathway, protein 
MDM2 degradation and tumor suppressor/protein p53 activation, and to interfere 
with angiogenesis, metastasis and epigenetic mechanisms (Amorim et al. 2013; 
Ghantous et al. 2013). 
A significant amount of research on cancer treatment has been aimed at the 
NF-kB pathway. NF-κB is a protein consisting of a p50 and p65 subunit and, when 
released from the IκB subunit, acts as a transcription factor on several genes in 
immune responses, inflammation pathways and apoptosis pathways and metastasis, 
by controlling response of other effectors such as cytokines, inflammatory molecules 
and cell adhesion molecules. Consequently, inhibition of the NF-κB complex, 
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specifically inhibition of its release from the IκB complex, reduces inflammatory 
response and prevents cancer growth  (Amorim et al. 2013; Chadwick et al. 2013).  
 
Table 1. Sesquiterpene lactones in cancer clinical trials. 
Compound Group of STL 
Plant 
species 
Cancer type 
Clinical 
trial 
Ref 
DMAPT (2a) Germacranolide 
Tanacetum 
parthenium 
Acute myeloid 
leukemia (AML) 
Acute lymphoblastic 
leukemia (ALL) 
Phase I 
(Ghantous et al. 
2010) 
Artesunate 
(3) 
Cadinanolide 
Artemisia 
annua L. 
Breast and colorectal 
cancer 
Non-small cell lung 
cancer 
Uveal melanoma 
Laryngeal carcinoma 
Phase II 
(Berger et al. 
2005; Efferth et 
al. 2001; 
Ghantous et al. 
2010; Singh & 
Verma 2002) 
Artemether 
(4) 
Cadinanolide 
Artemisia 
annua L. 
Pituitary 
macroadenoma 
Phase II 
(Ghantous et al. 
2010; Singh & 
Panwar 2006) 
Thapsigargin 
(5) 
Guaianolide 
Thapsia 
garganica L. 
Breast, kidney and 
prostate tumors 
Phase I 
(Ghantous et al. 
2010) 
 
 
The germacranolide parthenolide (2), [4α, 5β-epoxy-germacra-1-(10),11-(13)-
dien-12,6α-olide] – an epoxy-costunolide – is a recognized NF-kB inhibitor. It has been 
isolated from several different species in the Asteraceae family, being the major 
active principle of Tanacetum parthenium. In the past few years, an increasing 
interest has been observed in this sesquiterpene lactone, due to its significant 
antitumor activity. The latter is a result of its strong inhibition of NF-kB, by targeting 
multiple steps along the NF-kB signaling pathway, including the modification of the 
NF-kB p65 subunit and suppressing the activity of the upstream IkB kinase complex 
leading to the stabilization of the NF-kB inhibitors, IkBa and IkBb. The nucleophilic 
attack by parthenolide happens through the αMγL ring and epoxide moieties that 
target specific nucleophiles but not others (Ghantous et al. 2013; Ghantous et al. 
2010; Nasim & Crooks 2008).  
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Figure 3. Structures of STLs in clinical trials and others related. 
 
However, the low oral bioavailability of PTL, due to poor water-solubility 
(0.169 µM/mL maximum solubility in serum), and its indiscriminate reaction towards 
biological nucleophiles are a major limitation for its clinical use and development 
(Fardella et al. 1999; Ghantous et al. 2013; Nasim & Crooks 2008; Neelakantan et al. 
2009). 
Prompt by the above mentioned, new strategies consisting of derivatizing STLs 
into amino analogs have emerged, in which an amine is added into the αMγL of STLs 
to mask this group from nucleophiles and increase water solubility while retaining 
biological activity (Woods et al. 2013; Neelakantan et al. 2009).  
Thus, the Michael addition of the secondary amine dimethylamine led to the 
synthesis of the more water-soluble and orally bioavailable analog of PTL, 
dimethylaminoparthenolide (DMAPT), as illustrated in Figure 4. In fact, 
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pharmacokinetic analysis of in vivo studies in the rat showed that DMAPT has an oral 
bioavailability of around 70%, being predominantly metabolized into a product of 
mono N-demethylation (Chadwick et al. 2013; Neelakantan et al. 2009). 
 
 
Figure 4. Semi-synthesis of DMAPT (2a) by Michael addition of dimethylamine to PTL (2). 
 
DMAPT causes apoptosis by decreasing the binding of the Rel-A subunit of NF-
κB to DNA, supressing the transcription of numerous NF-κB-regulated genes, 
associated with cancer cell survival and resistance to chemotherapy (Neelakantan et 
al. 2009). 
 
1.2. Project presentation 
 
Two new sesquiterpene lactones of the guaianolide type - grosshemin 2,3-
dihydroxyisobutyrate (6) and dehydrogrosshemin-2,3-dihydroxyisobutyrate (7) – were 
previously isolated from Centaurea ornata (Bastos et al. 1994). Germacranolides, 
eudesmanolides, elemanolides and guaianolides are typically found in representatives 
of the genus Centaurea (Bruno et al. 2005).   
Moreover, their structure has been elucidated by Nuclear Magnetic Resonance 
(NMR). The only structural differences among these guaianolides is a ketone group at 
C-3 and a methyl group (C-15), in (6), which is replaced by a hydroxyl group and a 
methylene group, respectively, in (7), as can be seen in Figure 5.  
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Figure 5. Structures of grosshemin 2,3-dihydroxyisobutyrate (6) and dehydrogrosshemin-2,3-
dihydroxyisobutyrate (7). 
 
STLs’ anti-tumoral activity has been scientifically demonstrated by several 
research groups for different compounds. On the other hand, it is important to 
evaluate the toxic side-effects of these compounds, i.e. their safety. Thus, before 
specific studies of anti-tumoral activity of these two compounds are performed on 
cancer cell lines, a preliminary screening has been conducted, to assess the potential 
citotoxicity of compound 6 towards human fibroblasts, which are normal, non-
neoplastic cells.  
Once these compounds have been proven to possess anti-tumoral activity, and 
having isolated plant fractions which contain these STLs, the main challenge is the 
development and implementation of a method for their purification and separation 
from a mixture, as pure substances, using efficient preparative chromatographic 
separation techniques. In this sense, this study also aims at making use of semi-
preparative high-performance liquid chromatography (HPLC) to develop a 
chromatographic method that enables the separation of compounds 6 and 7 from a 
mixture, obtained from different fractions of the plant.  
Furthermore, in continuation of studies on the chemical modification of 
sesquiterpene lactones to produce new aminoderivatives with improved 
bioavailability, due to increased water-solubility and lower toxicity while retaining 
their anti-tumoral activity, new aminoderivatives based on the known and available 
grosshemin guaianolides (6) and (7) have been synthesized. 
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2. State of the art 
2.1. High Performance Liquid Chromatography 
 
In general, chromatographic methods for the separation in individual 
components, including high-performance liquid chromatography (HPLC), supercritical 
fluid chromatography (SFC), gas chromatography (GC), thin layer chromatography 
(TLC), overlay pressure liquid chromatography (OPLC) and micellar electrokinetic 
chromatography (MEKC), are used to identify/purify new STLs. Furthermore, these 
methods are combined with analytical characterization techniques such as mass 
spectrometry (MS), diode array detection (DAD) and nuclear magnetic resonance 
(NMR), resulting in GC–MS, HPLC–DAD, HPLC–NMR or SFC–DAD, by which 
characterization and often identification of the separated compound is possible 
(Fritsche et al. 2002; Merfort 2002). 
HPLC with ultraviolet detection (HPLC-UV) is often the preferred physical 
method of separation of these substances due to the low volatility and occasional 
thermolability of STLs (Merfort 2002). However, when sesquiterpene lactones have 
low molar absorption coefficient in the UV range, owing to weakly absorbing 
chromaphoric groups or no chromophores at all, HPLC-UV is not sensitive enough and, 
thus, unsuccessful for STL analysis (Merfort 2002; Yang et al. 2012).  
Hence, the combination of HPLC with mass spectrometry (MS) has become 
extremely helpful in the detection and identification of STLs. In fact, it allows, not 
only the separation of the components of a mixture, but also the characterization of 
those components. Mass spectrometry can be used for obtaining information even 
when the compounds are not completely separated. The nature of MS detector allows 
the quantification of more than one compound even if co-eluted, as long as the ions 
have different mass/charge (Merfort 2002; Skoog et al. 2007). 
Furthermore, high-performance separation techniques are often combined 
with a structurally elucidatory spectroscopic method, such as nuclear magnetic 
resonance (HPLC-NMR). NMR spectroscopy enables quantitative analysis, with 
practical application for mixture analysis and purity assessment due to an inherent 
characteristic in which integrated signal intensity (signal area) in the spectrum is 
proportional to the number of nuclei giving the corresponding resonance (Merfort 
2002; Staneva et al. 2011). 
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On the other hand, efficient preparative chromatographic separation 
techniques are important for the rapid isolation of target compounds once their 
bioactivity has been confirmed. Essentially, while analytical chromatography does 
not depend on the recovery of a sample, preparative chromatography is a 
purification process employed with the purpose of isolating a pure substance from a 
mixture (Hostettmann et al. 1998). 
  The literature provides very few reports on the high-performance liquid 
chromatography using a semi-preparative column aiming at the separation and 
recuperation of sesquiterpene lactones contained in a plant fraction. Researches 
rather focus on the analytical separation, characterization and quantitative 
determination of these biologically active compounds.  The HPLC methods for the 
separation of STLs by several authors are reviewed in Table 2. 
It is noted that C18 is the most common silica-based stationary phase in the 
researches carried out in this field. Moreover, methanol-water is the preferred 
mobile phase, both in isocratic and gradient elution. 
 
2.2. Semi-synthesis of aminoderivatives 
 
The pharmacological benefit of sesquiterpene lactones has been extensively 
demonstrated and its biological effect has been attributed to the α-methylene-γ-
lactone group. Nevertheless, their poor aqueous solubility and non-selective binding 
as a Michael acceptor at undesired targets renders unsuitable compounds for clinical 
development as a drug entity (Chadwick et al. 2013; Dell’Agli et al. 2009; Ghantous 
et al. 2010; Ghantous et al. 2013; Guzman et al. 2005; Guzman et al. 2007; Nasim & 
Crooks 2008; Neelakantan et al. 2009; Woods et al. 2013).  
Therefore, a series of more water-soluble analogs have been synthesized. 
Ghantous et al. (2013) verified that reduction of the α-methylene, epoxidation of the 
endocyclic alkene or oxidation of the allylic methyl groups reduces activity of the 
derivatives. Thus, new studies were directed towards the synthesis of 
aminoderivatives.  
Woods et al. (2013) described the semi-synthesis of serveral aminoderivatives 
of STLs, such as helenalin, ambrosin, costunolide and saussureamines A–E, 
alantolactone and parthenolide (PTL, 2). Besides its chemical development, its 
pharmacological applications and potential as a clinical applicant is also addressed. 
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Table 2. Analytical and semi-preparative separations of sesquiterpene lactones by HPLC. a 
Structureb Column Solventc Flow rate (ml/min) Reference 
Analytical separation 
8,9 
C18 (10 µm; 200x4.0 
mm) 
MeOH/H2O 
(30:70) 
0.8 
(Fardella et al. 
1999) 
10 C18 (5 µm; 250x3.0 mm) MeOH/H2O var. 0.5 
(Ferioli & 
D’Antuono 2012) 
11 C18 (5 µm; 250x4.6 mm) 
IPA/MeCN/MeOH/ 
H2O/HCOOH var. 
1.0 
(Fritsche et al. 
2002) 
12 C18 (5µm; 250×4.6 mm) MeCN/H2O (55:45) 1.0 (Huo et al. 2010) 
13 C18 (5 µm; 250x4.6 mm) 
MeCN/H2O,H3PO4 
var. 
1.0 (Sessa et al. 2000) 
14 C18 (5 µm; 250x4.0 mm) 
MeOH/H2O 
(50:50) 
1.0 
(Spring et al. 
2003) 
15 C18 (5 µm; 250×4.6 mm) 
MeOH/H2O 
(70:30) 
- 
(Zhang et al. 
2011) 
Semi-preparative separation 
16 
C18 (6 µm; 300×7.8mm) 
MeOH/H2O 
(47:53) 
1.0 (Huo et al. 2010) 
17 
MeOH/H2O 
(52:48) 
18 C18 (250x21.2 mm) MeCN/H2O var. 10 (Igual et al. 2013) 
19 
C18 (5 µm; 250×30.0 
mm) 
MeOH/H2O 
(70:30) 
- (Liao et al. 2012) 
20 C18 (10 μm; 250x10 mm) MeOH/H2O var. 1.5 (Youn et al. 2014) 
a Extended description of the chromatographic conditions in Appendix A.1; b structures are presented in Appendix 
A.2; c variable mobile phase conditions. 
 
Parthenolide represents the most well studied case for the development of a 
synthetic aminoderivative, due to its promising biological activity which has 
compelled substantial efforts for its clinical application as an anticancer agent 
(Dell’Agli et al. 2009; Guzman et al. 2007; Guzman et al. 2005; Neelakantan et al. 
2009; Woods et al. 2013). 
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Several authors have synthesized PTL analogs to identify a compound with 
improved water solubility and bioavailability. The general procedure consists in the 
Michael addition of an amine to the α-methylene-γ-lactone of PTL (2) (Figure 6). 
 
 
Figure 6. Synthesis of aminoparthenolide analogs. 
 
Nasim & Crooks (2008) describe the synthesis and antileukemic properties of 
several parthenolide analogs derived from arylalkyl, heteroarylalkyl and alkyl 
amines. 
Ghantous et al. (2013) demonstrated that conjugate addition of aromatics, 
particularly a tyramine moiety, or aliphatic amines to the α-methylene yields 
compounds with similar potency and better hydrophilicity than PTL. Among aliphatic 
acyclic derivatives, secondary amines, such as dimethylaminoparthenolide (DMAPT, 
2a) bearing a N, N-dimethylamino group, are more potent than are primary amines 
against acute myeloid leukemia (AML) cells. Furthermore, within secondary acyclic 
amines, analogs with at least one N-methyl group and short N-linked chains have 
higher anti-leukemic activity. The aliphatic acyclic amine DMAPT was considered to 
be the most promising analog due to increased water-solubility while retaining 
activity, demonstrated by the elimination of 93% of primary AML cells.  
Moreover, Guzman et al. (2007) also verified the effectiveness of DMAPT in 
eliminating human AML stem and progenitor cells without apparent harm to normal 
hematopoietic stem and progenitor cells. 
The abovementioned findings led to the initiation of an ongoing phase I 
clinical trial for DMAPT. Thus, in the present study, the semi-synthesis of 
dimethylaminoderivatives of compounds 6 and 7 will be performed, which will 
produce new data. 
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2.3. Biological activity: cytotoxicity  
 
Numerous studies report on the in vitro cytotoxicity of STLs towards tumoral 
cell lines (Berger et al. 2005; Fernandes et al. 2008; Foster et al. 2011; Ghantous et 
al. 2013; Ghantous et al. 2010; Guzman et al. 2007; Guzman et al. 2005; Liao et al. 
2012; Nasim & Crooks 2008; Rivero et al. 2003; Singh & Lai 2001; Youn et al. 2014). 
In some instances, STLs such as parthenolide were shown to sensitize tumour cells to 
radiotherapy (Mendonca et al. 2007) or to other conventional drugs (Yip-schneider et 
al. 2005).  
However, there are only a few studies dealing with the effects of STLs on 
normal, non-neoplastic cells (Amorim et al. 2013). Burim et al. (1999, 2001) reported 
that centratherin and glaucolide B induced sister-chromatid changes and structural 
chromosomal aberrations in vitro in human peripheral blood lymphocytes, 
respectively. However, Guzman et al. (2005) reported that parthenolide specifically 
targeted leukemia cells, while sparing normal hematopoietic cells. This seems to 
indicate that STLs may be promising anti-neoplastic agents, with high selectivity 
towards tumour cells. 
Furthermore, to date no information is available on the cytotoxic properties 
of these two guaianolides (6 and 7). 
Bearing this in mind, it seems reasonable to begin the preliminary in vitro 
cytotoxicity studies of the present compounds on normal human fibroblasts, in order 
to assess their toxicity towards non-tumoral cells.  
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3. Materials and methods 
3.1. Purification of STLs from a mixture 
 
3.1.1. Samples preparation 
The two guaianolides (6 and 7) were previously isolated from aerial parts of 
Centaurea ornata (Bastos 1996). The stock solutions for each compound were 
separately prepared by dissolving the accurately weighed reference compound to a 
final concentration of 10000 ppm and stored at 4⁰C. This solutions were further 
diluted to appropriate concentrations (500 ppm) for HPLC analysis, both as separate 
samples and as a mixture of the two compounds, and filtered through nylon filters 
(diameter: 13 mm; pore dimension: 0.22 µm) from Nantong FilterBio Membrane Co., 
Ltd prior to injection in the HPLC column. 
 
3.1.2. Reagents 
HPLC grade acetonitrile and methanol, purchased from VWR International, 
were used for the HPLC analysis and the latter also for sample preparation. Before 
use in HPLC, distilled water was filtered through Sartolon® polyamide membrane 
filters (diameter: 47 mm; pore dimension: 0.45 µm) from Sartorius AG and all 
solvents were degassed in an ultrasonic bath at room temperature for ca. 20 min. 
 
3.1.3. HPLC and chromatographic conditions 
HPLC analyses were carried out on a Jasco modular liquid chromatograph, 
equipped with an intelligent HPLC pump (mod. PU-2080 plus), an autosampler (mod. 
AS-2057 Plus) and a diode array UV/Vis detector (mod. MD-2015, wavelength range 
200 ~ 900 nm, quartz flow cell, 10 mm optical path). A VarioPrep® Nucleosil C18 (250 
x 10 mm id, 5 µm particle size, 100 Å pore size) semi-preparative column from 
Macherey-Nagel was employed. 
STLs elution was performed in isocratic and gradient mode using various 
gradient programs, employing the following solvent system: mobile phase A: water; 
mobile phase B: methanol or acetonitrile. The flow rate was 1 mL/min and the 
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injection volume was either 20 µL or 100µL. The column temperature was set at 
25⁰C. Data were processed by the software Jasco ChromPass (v. 1.8.6.1).  
 
3.2. Semi-synthesis of aminoderivatives 
 
3.2.1. Preparation of DMA derivatives 
Treatment of ca. 10 mg of a 40 mM methanolic solution of the STL (6 and 7) 
with one equivalent of dimethylamine led to significant consumption of the STL (6 
and 7) within 12 h at room temperature. The samples were further treated with 
slightly acidified (HCl) water to remove excess of dimethylamine reagent. 
Afterwards, the derivatives (6a and 7a) were extracted with ethyl acetate and the 
solvent was eliminated by evaporation.  
 
3.2.2. Nuclear Magnetic Resonance (NMR) analysis 
NMR spectra of 6 and 7 were recorded on a Bruker Avance III - 400 
spectrometer (operating at a frequency of 400 and 100 MHz, for 1H NMR and 13C NMR, 
respectively) while spectra of 6a and 7a were recorded on a Bruker ASCEND 700 
spectrometer (operating at a frequency of 700 and 175 MHz, for 1H NMR and 13C NMR, 
respectively). The samples (compounds 6, 7, 6a and 7a) were dissolved in 0.5 mL of 
deuterated chloroform (CDCl3). Chemical shifts were reported in part per million 
(ppm, δ) using residual solvent signals as internal standard (7.26 ppm and 77.00 ppm, 
for 1H NMR and 13C NMR, respectively). 1H-NMR, 13C-NMR, DEPT-135, COSY, HSQC and 
HMBC correlation techniques were applied to assign the chemical shifts of proton and 
carbon atoms.  
 
3.3. Cytotoxicity assays  
 
In vitro cytotoxicity assays were performed in normal human fibroblasts (HFF-
1, ATCC, SCRC1041) as a means to evaluate the potential toxicity of compound 6 
towards non-neoplastic cells. In fact, evaluating the toxic side-effects of anti-
neoplastic compounds, i.e. their safety, is a critical part of the drug development 
process. However, there is little data available concerning the toxic side-effects of 
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sesquiterpene lactones (Amorim et al. 2013). Parthenolide and other related 
compounds, that have recently reached clinical trials, are reported to show minimal 
non-target toxicity (Guzman et al. 2007). In the present study, the cytotoxic effect 
of compound 6 was tested using the resazurin assay (Riss et al. 2013), employing 
three drug concentrations, similar to those for which most STLs usually show 
therapeutic/cytotoxic activity towards neoplastic cells (Ghantous et al. 2013). 
 
3.3.1. General cell culture conditions 
In vitro assays were performed using human foreskin fibroblasts HFF-1 (ATCC,  
SCRC1041), grown in Dulbecco’s modified Eagle’s media (DMEM) (Gibco, 21885-025) 
supplemented with 10% (V/V) newborn calf serum (Gibco, 10270-106) and 1% (V/V) 
penicillin/streptomycin (biowest, L0022-100) 1% (V/V) – (DMEM+), at 37.0⁰C, in a 
fully humidified air containing 5% CO2. The cells were fed every 3 days. When 90% 
confluence was reached, cells were detached from T75 flasks using 2 mL of a 0.25% 
(w/V) trypsin (Sigma Aldrich, T4799-25G) - PBS 1x [EDTA ( 2,2',2'',2'''-(Ethane-1,2-
diyldinitrilo)tetraacetic acid) 0.05 % (w/V), glucose 0.1 % (w/V)] solution and 
resuspended in culture medium at cellular density according to the assay. All assays 
were performed with 6 replicates. Results are presented as mean.  
Buffer PBS 1x was prepared and contains 4g NaCL, 0.1 g KCl, 0.72 g Na2HPO4 
 
and 0.12 g KH2PO4 per 1 L dionized H2O, with a pH of 7.4. 
 
3.3.2. Resazurin assay 
HFF-1 cells were seeded in 96 well plates (150 µL/well) at a density of 2 x 104 
cells/mL (3000 cells/well). After reaching a state of subconfluence (24h), DMEM+ was 
removed and cells incubated with 6 in DMEM+ at concentrations of 0.28, 1.38 and 
2.75 μM. At 24, 48, and 72h, 20 µL (1 mg/mL) resazurin (Sigma Aldrich, R7015-5G) in 
PBS 1x was added to each well. Cells were incubated for 3h and fluorescence 
(λex/em=530/590 nm) read in a fluorometer (Biotek – Synergy Mx). Moreover, at these 
time-points plates were observed in an inverted fluorescence microscope (Carl Zeiss – 
Axiovert 200) and phase contrast images captured. 
Negative control was performed incubating cells with DMEM+ and with DMEM+ 
containing DMSO at the maximum DMSO concentration used in the assays. The 
positive control was done incubating with triton 0.1 wt.%. Cell viability (%) was 
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calculated as follows: Fluorescence of sample/ Fluorescence of negative control * 
100. 
 
3.3.3. Statistical analysis 
The cell viability (%) values for 24h, 48h and 72h, for each tested 
concentration, were compared using the ANOVA approach using the R-project 
software version 3.1.0 from Institute for Statistics and Mathematics of 
Wirtschaftsuniversität Wien. 
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4. Results and discussion 
4.1. Purification of the STLs from a mixture 
 
The chromatographic work was developed from the start using a semi-
preparative column, rather than with an analytical column in the initial stages of the 
method development, in order to avoid time-consuming optimizations that might 
have been necessary when the method was scaled-up, i.e., when larger volumes 
were injected. 
Different chromatographic conditions were investigated in order to obtain 
chromatograms with the best possible resolution and sensitivity within a reasonable 
run time, i.e., to obtain better separation of adjacent peaks within a shorter time 
period. On the basis of the 3D UV spectra plot, the signal intensity was higher at 210 
nm, thus detection was set at this wavelength, which was also selected by other 
authors (Appendix A.1).    
Two mobile phase systems, methanol–water and acetonitrile–water, were 
tested; the acetonitrile–water system did not result in a better selectivity of 
separation (elution) of the investigated compounds, in comparison with the 
methanol-water system, though it has a higher elution capacity, i.e., lower retention 
times are obtained. Thus, since acetonitrile is a more expensive solvent, 
optimizations were proceeded with methanol as the organic solvent.  
Furthermore, formic or trifluoroacetic acid at low (for instance, 0.1%) 
concentrations are commonly added to the mobile phase to control retention of 
compounds. Adding acid (proton donor) increases the hydrogen ion concentration 
(lowers pH) of the solution, which will influence the extent of the analyte ionization. 
Ionised form is more polar and, as a result, less well retained under reversed phase 
conditions (McMaster 2007; Snyder et al. 1997). However, addition of formic acid 
0.1% to the mobile phase was found to have no significant improvement on the 
separation. 
Elution was performed isocratically (the water-methanol composition was 
kept constant during the separation process) as well as by using a solution gradient 
mode (the water-methanol composition was altered throughout the separation 
process, by decreasing the polarity of the mobile phase, i.e., by increasing the 
proportion of the organic (non-polar) solvent).  
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Despite the fact that isocratic conditions are most often employed in 
preparative HPLC to minimize operating problems, a fair number of gradient elutions 
have been reported for those cases in which separations are troublesome 
(Hostettmann et al. 1998) (Appendix A.1). In fact, for this particular separation of 
two hydrophobic compounds with extremely high structural and stereochemical 
similarity, the most satisfactory results were obtained using a gradient elution. 
Different gradient mode compositions, using H2O (A)/ MeOH or MeCN (B) as the 
mobile phase, employed for the HPLC analysis of STLs 6 and 7 are presented in 
Appendix A.3. 
Moreover, four sets of chromatograms using two different gradient-elution 
compositions, illustrated in Figure 7, are shown in Figure 8. 
 
 
 
 
Figure 7. Gradient elution programs employed to obtain the chromatographic separations. (a) 
Gradient program 1; (b) gradient program 2. 
 
In Figure 8 (a, b) the two STLs, 6 and 7, were analyzed independently, while 
in Figure 8 (c, d) these compounds where in a mixture 1:1, thus a single sample was 
analyzed. With the mobile phase variation applied in Figure 8a, a RT of 13.21 min for 
6 and 13.27 min for 7 was obtained, from which can be concluded that the two 
molecules would co-elute if present in the same sample. The testing of different 
chromatographic conditions led to the observation that shortening the run time 
compromised the separation of the two compounds. It was also verified that both 
compounds elute when the percentage of methanol in the mobile phase is 100%. 
Comprehensive optimizations lead to the separation obtained in Figure 8b, 
where a RT of 41.05 min for 6 and 42.09 min for 7 was obtained. Even though the 
difference in the retention times of 6 and 7 was not considerable, with peaks with 
relatively low resolution, and the run time was not as short as ambitioned at first, 
purification studies aiming at the isolation of a pure substance from the mixture 
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were continued. Thus, the separation obtained in Figure 8c, where a RT of 40.81 min 
for 6 and 41.82 min for 7 was achieved, confirmed that under the same 
chromatographic conditions, separation of the substances from a single sample did 
not undergo substantial modifications. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. HPLC chromatograms obtained for the separation of 6 and 7. Conditions: A: gradient elution 
(Figure 7a), 20 µL injection, separate samples; B: gradient elution (Figure 7b), 20 µL injection, separate 
samples; C: gradient elution (Figure 7b), 20 µL injection, 6 and 7 in mixture (1:1); D: gradient elution 
(Figure 7b), 100 µL injection, 6 and 7 in mixture (1:1). 
 
Within the context of this work, the main advantage of using semi-preparative 
chromatography is the possibility of having high levels of sample load, which would 
ultimately result in the recovery of pure substances. For such, the large volumes of 
eluted solvent would require a suitable fraction collector for its handling. 
In this sense, a 100 µL sample of the mixture of the two compounds was 
loaded onto the semi-preparative column and the separation in Figure 8d was 
t (min) 
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attained. A decrease in chromatographic resolution due to peak width broadening is 
observed leading to a more significant co-elution of 6 and 7, which translates into 
inability to separate these two compounds using a RP18 column. On the other hand, a 
reduction in the retention times of 6 (38.81 min) and 7 (39.89 min) was observed. 
Minor variations in the retention times of the compounds (ca. 1 min) were expected 
since the samples were analyzed on different days and the column pressure may 
vary. Additionally, throughout the period of the present work, solvents from 
different batches are used and the characteristics of the distilled water may vary. 
Nonetheless, in the separation showed in Figure 8d there was a decrease of 
approximately 2 min in the RT of both STLs when compared to the separation 
presented in Figure 8c. This may be explained considering that a larger quantity of 
sample (more mass of compound) was loaded onto the column impairing the 
interaction of some molecules with the stationary phase, which eluted earlier, thus 
carrying the rest of the sample, and ultimately resulting in lower retention times.   
Fardella et al. (1999) also analyzed two guaianolides - grosheimin and 
deacylnaropicrin (compounds 8 and 9; Appendix A.1 and A.2) - structurally similar 
between them and similar to 6 and 7 and likewise it was verified that their retention 
times presented only a small difference (0.67 min). 
These results may be explained considering the mechanism by which the 
octadecyl (C18) carbon chain – bonded silica stationary phase interacts with the 
molecules in the mobile phase. The major interactions that take place between the 
two phases are hydrophobic interactions, which consist in induced dipole-dipole 
forces between the aliphatic chains of the modified silica particles and the analyte 
molecules. Consequently, these interactions do not distinguish between a compound 
with a hydroxyl group and one with a carbonyl group in its turn. Given the fact that 
this is the only chromatographically detectable difference between these STLs, the 
used C18 column does not possess selectivity that allows for their effective 
separation. 
In light of the aforementioned findings, an octyl (C8) column which exhibits 
lower hydrophobicity when compared to the C18 column (lower intensity of 
hydrophobic interactions and shorter retention times) may also not be suitable for 
the separation of these two guaianolides under the same mobile phase conditions.    
  In a new approach to this problem, a column that allows for multiple 
interaction mechanisms between the coating particles and the molecules, such as a 
biphenyl bonded silica stationary phase column, should be considered. 
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The biphenyl phase is composed of two phenyl groups bonded end-to-end and 
an aryl linker to the silica particles. Its main advantage is the ability to resolve 
compounds using  interactions, commonly referred to as aromatic selectivity, 
resulting in different selectivity to alkyl phases like C18. When compared to single 
phenyl ring phases, it is more hydrophobic and provides a larger electron cloud, 
therefore maximizing hydrophobic retention and increasing the area available for  
interactions, providing the highest degree of aromatic selectivity available (Chust 
2014; Restek Corporation 2008). When applied to this particular separation, the 
electrons of the phenyl group would likely interact with the  electrons in the 
double bond (C=O) present in compound 6, favoring its retention and, thus, 
increasing the difference between the retention times of 6 and 7, making it possible 
for their semi-preparative separation. 
Furthermore, in HPLC, the mobile phase can be altered to enhance a 
separation or to obtain a desired resolution. With the biphenyl phase, this can be 
achieved with simple mobile phase changes. The choice of organic solvent used in 
the mobile phase can alter the selectivity by switching between two separation 
mechanisms: dispersive (hydrophobic) interactions and interactions. Whereas 
using acetonitrile makes a biphenyl column more C18-like in its retention and 
selectivity, due to the triple bond (C≡N) which restrains interactions of the 
analyte with the stationary phase, methanol prompts aromatic selectivity 
(interactions) (Chust 2014; Restek Corporation 2008).  
Thus, instead of attempting to expand the use of the traditional C18 column 
with numerous additives and running conditions alterations that is time-consuming, 
this separation can be further transformed with the selectivity and performance that 
the biphenyl column would provide.  
 
4.2. Semi-synthesis of aminoderivatives 
 
The semi-synthesis of the dimethylaminoderivatives of STLs 6 and 7 was 
performed so that, afterwards, it is possible to compare the bioactivity of these 
compounds prior to and after derivatization. 
N, N-dimethylaminogrosshemin-2,3-dihydroxyisobutyrate (6a) and N, N-
dimethylaminodehydrogrosshemin-2,3-dihydroxyisobutyrate (7a) were obtained 
through a Michael addition of dimethylamine  to the α-methylene-γ-lactone ring, 
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more specifically to the electrophilic vinylic carbon C-13, of 6 and 7, respectively 
(Figure 9). 
 
 
Figure 9. Semi-synthesis of the diamino derivatives of STL 6 (6a) and STL 7 (7a). 
 
Structure elucidation has an important role in all of the studies concerning 
the full characterization of STLs, namely in the confirmation of semi-synthesis of 
derivatives. Thus, the complete characterization of STLs 6 and 7 by NMR was 
previously performed, including different experiments: 1H-NMR, 13C-NMR, HSQC, 
COSY and HMBC in order to verify the anticipated modifications in the NMR spectra of 
the respective derivatives, 6a and 7a, respectively. 
Sesquiterpene lactones 6 and 7 have a C15 guaianolide backbone, with a 2,3-
dihydroxyisobutyrate side-chain at C-8, presenting only slight structural differences 
in the cyclopentene ring (C-1 to C-5), which, consequently, yields very similar 1H-
NMR and 13C-NMR records (Figure 10 and 11). This similarity is evidenced in the 13C-
NMR spectra presented in Figure 10 (b, c). Major differences are observed at the C-3, 
C-4 and C-15 level. While compound 6 exhibits a ketone carbonyl carbon (C-3 at δ 
218.32 ppm), a methynic carbon (C-4 at δ 46.97 ppm) and a methylic carbon (C-15 at 
δ 15.51 ppm), in compound 7 the unsaturation occurs at the C-4 and C-15 
(quaternary carbon and methylenic carbon, respectively at δ 152.16 and 114.24 ppm) 
level and C-3 is a methynic carbon (CH) with a chemical shift (δ 73.75 ppm) typical 
of a carbon directly bonded to an oxygen atom. 
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Figure 10. 13C NMR spectra (CDCl3) of STLs 6 and 7. (a) DEPT-135 sprectrum of STL 7; (b) normal 
13C NMR spectrum of STL 7; (c) 13C NMR spectrum of STL 6. 
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Figure 11. 1H NMR spectrum (CDCl3) of STL 7 with amplifications of two regions. 
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Figure 10a shows the DEPT-135 spectrum of compound 7 that allows for the 
distinction between the four types of carbons: methynic (CH) and methylic (CH3) as 
positive signals; methylenic (CH2) as negative signals; and eliminating quaternary 
signals (for instance C-4), which are identified by comparison with the 13C-NMR 
spectrum. 
Likewise, the 1H-NMR spectra of both compounds present an array of similar 
signals, namely the ones corresponding to the α-methylene-γ-lactone ring: two 
olefinic protons corresponding to H-13β an H-13α, in the region between δ 5.6–6.5 
ppm. 
The 1H-NMR spectrum of compound 7, with amplifications of the regions 
between δ 5.9-6.2 and 1.0–2.5 ppm, is presented in Figure 11. These two regions 
undergo significant modifications upon preparation of the N, N-dimethylamino 
derivatives. 
Hence, the detailed analysis of the 1H NMR spectra of 7a, showed the absence 
of the two olefinic proton resonances of 7 at δ 5.95 and 6.20 ppm (corresponding to 
H-13β an H-13α, respectively) and the appearance of one methynic and two non-
equivalent methylenic protons at δ 2.33-2.37, 2.09 and 2.06 ppm (corresponding to 
H-11, H-13α an H-13 β, respectively). Another evidence is the appearance of a singlet 
at δ 2.66 ppm due to the resonance of the two N-methyl groups. Furthermore, in the 
13C NMR spectrum, besides the appearance of a signal due to the two magnetic 
equivalent N-methyl carbons at δ 34.84 ppm, the shift of carbon C-11 resonance from 
δ 137.04 ppm to δ 45.48 ppm (a 92.56 ppm difference) and carbon C-13 resonance 
from δ 123.81 ppm to δ 57.77 ppm (a 66.04 ppm difference) can be highlight.  
The 13C NMR and 1H NMR assignments (δ in ppm) around the -methilene γ-
lactone, for compounds 6 and 7, and their dimethylaminoderivatives 6a and 7a, are 
represented in Figure 12. Accordingly, these data confirm that the amination of the 
conjugated exocyclic double bond of 6 and 7 had occurred. 
Elucidative amplifications of HSQC, COSY and HMBC spectra of compound 7 
can be found in Appendix A.4 while the complete attribution of the 13C NMR and 1H 
NMR data of the four compounds (6, 7, 6a and 7a) are present in Appendix A.5. 
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Figure 12. 
1
H and 
13
C NMR assignments (δ in ppm) for compounds 6, 7 and their diamino derivatives (6a and 7a). 
 
4.3. Cytotoxicity assays 
 
In spite of the ever-increasing evidence that STLs have anti-tumoral 
properties, the extensive reactivity of these compounds also results in toxic effects 
towards humans, which must be carefully assessed to ensure their safe utilization 
(Amorim et al. 2013). 
The structure-activity relationship of STLs for the cytotoxic and anti-tumoral 
effects is well studied, being attributed to the α-methylene-γ-lactone group. 
Moreover, the lipophilicity of these substances can considerably influence 
pharmacokinetic studies. 
In the present study, in vitro cytotoxicity assays were performed in normal 
human fibroblasts as a means to evaluate the potential toxicity of compound 6 
towards non-tumoral cells. 
Observation of cultured cells on an inverted fluorescence microscope (Carl 
Zeiss – Axiovert 200) did not reveal any conspicuous differences between control and 
exposed cells at any time-point. Phase contrast images captured by observation of 
the plates are presented in Figure 13. No significant alterations in the morphology of 
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the cells are observed when comparing cells exposed to 2.75 μM with control cells, 
at 24h (a and b, respectively), 48h (c and d, respectively) and 72h (e and f, 
respectively). 
 
 
Figure 13. In vitro cytotoxicity experiments on human foreskin fibroblasts. (a), (c) and (e) Control 
cells (DMEM+/DMSO) at 24h, 48h and 72h, respectively; (b), (d) and (f) cells exposed to 2.75 μM of 
compound 6 at 24h, 48h and 72h, respectively. Inverted fluorescence microscopy 400x. 
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The percent viability of cells, for time-points at 24, 48 and 72 hours, treated 
with three different concentrations of compound 6 (0.28, 1.38 and 2.75 μM) is 
plotted in Figure 14.  
 
 
Figure 14. In vitro cytotoxicity experiments on human foreskin fibroblasts. The viability of cells 
exposed at 24h, 48h and 72h, to 0.28, 1.38 and 2.75 μM of compound 6 is expressed as a percentage of 
control cells (DMEM+/DMSO) viability.   
 
The statistical analysis revealed that for the higher concentration of 6, 2.75 
μM, that the cells were exposed to, as well as for 1.38 μM, there was no significant 
differences between the percentage of viable cells at 24, 48 and 72 hours (p>0.05). 
On the other hand, contrary to expected, in the lower concentration of 6, 0.28 μM, 
that the cells were exposed to there was significant differences between the viability 
of cells at 24, 48 and 72 hours (p<0.05). Thus, it is assumed that an error occurred, 
considering that the lower the concentration, the more errors are associated with 
the measurement. 
The phase contrast images have a morphological visual aspect and, hence, are 
illustrative of the results demonstrated in Figure 14. Moreover, they complement the 
cell viability (%) results. 
These preliminary data suggest that this sesquiterpene lactone is not toxic 
towards normal human foreskin fibroblast cells in concentrations of up to 2.75 μM 
after a period of incubation from 24h – 72h, i.e., it does not show off-target toxicity. 
Moreover, these results are in accordance with the ones reported by other authors 
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concerning parthenolide and other related compounds that have recently reached 
clinical trials, which presented minimal non-target toxicity (Guzman et al. 2007). 
Nevertheless, further experiments should be performed, including treatment 
of cells with higher concentrations of compound 6, the use of a dispersant since the 
compound is lipophilic and eventually extend the time-points at which the 
fluorescence of the plates is read.   
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5. Conclusions 
5.1. General conclusions 
 
The main interest in sesquiterpene lactones is related to their anti-tumoral 
potential, since some of the STLs have been found to show enough potential to enter 
clinical trials. However, they present low oral bioavailability, due to poor water-
solubility, which translates into the need to synthesize more water-soluble 
derivatives of these compounds, more specifically aminoderivatives. On the other 
hand, the extensive reactivity of STLs also results in toxic effects towards humans, 
which require careful assessment to ensure their safe utilization. 
Semi-preparative separation of the two guaianolides (6 and 7) was attempted 
and different mobile phase conditions were tested. To address the purpose of the 
semi-preparative chromatography, a 100 µL sample of the mixture of the two STLs 
was loaded onto the C18 semi-preparative column. A decrease in chromatographic 
resolution due to peak width broadening was observed leading to a more significant 
co-elution of 6 and 7, with retention times of 38.81 min and 39.89 min, respectively, 
which translates into inability to separate these two compounds using a C18 column 
under the tested chromatographic conditions. 
Furthermore, N, N-dimethylaminogrosshemin-2,3-dihydroxyisobutyrate (6a) 
and N, N-dimethyl-aminodehydrogrosshemin-2,3-dihydroxyisobutyrate (7a) were 
obtained through a Michael addition of dimethylamine to the α-methylene-γ-lactone 
ring, more specifically to the electrophilic vinylic carbon C-13, of 6 and 7, 
respectively. 
The amination of the conjugated exocyclic double bond of 6 and 7 was 
confirmed by comparison of their 13C NMR and 1H NMR spectra with the complete NMR 
characterization of STLs 6 and 7. This analysis showed, for instance, the appearance 
of a singlet at δ 2.66 ppm due to the resonance of the two N-methyl groups, in the 1H 
NMR spectra, whereas in the 13C NMR spectra the appearance of a signal due to the 
two magnetic equivalent N-methyl carbons at δ 34.8 ppm can be highlighted.  
Finally, the preliminary in vitro cytotoxicity studies of compound 6 were 
performed on normal human fibroblasts, in order to assess their toxicity towards non-
tumoral cells. At the maximum concentration (2.75 μM) that the cells were exposed 
to, phase contrast images captured by observation of the plates on an inverted 
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fluorescence microscope revealed no significant alterations in the morphology of the 
cells when comparing cells exposed to 2.75 μM with control cells. In addition to the 
percent viability of cells data, these preliminary results indicate that STL 6 does not 
possess toxicity towards normal human foreskin fibroblast cells in concentrations of 
up to 2.75 μM after a period of incubation from 24h to 72h. 
 
5.2. Limitations and future work 
 
Throughout the present work some setbacks were found, regarding mainly the 
HPLC equipment, which were fortunately solved in due time. 
In a new approach to the separation of STLs 6 and 7 by semi-preparative 
HPLC, instead of attempting to expand the use of the traditional C18 column with 
numerous additives and running conditions alterations that is time-consuming, this 
separation may be further transformed with the selectivity and performance of a 
biphenyl column. 
If the separation is achieved, for the recovery of pure substances, the large 
volumes of eluted solvent would require a suitable fraction collector for its handling, 
which has already been set to operate, and an efficient evaporation method for 
multiple samples, such as a Multivapor that is available at LEPABE.  
Concerning the cytotoxicity assays, further experiments should be performed, 
including treatment of cells with higher concentrations of compound 6, the use of a 
dispersant since the compound is lipophilic and eventually extend the time-points at 
which the fluorescence of the plates is read. Likewise, cytotoxicity evaluation of 
compound 7 and of the dimethylaminoderivatives, 6a and 7a, should be executed. 
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Appendix  
A.1. Chromatographic conditions employed by several authors for the analysis of STLs using HPLC 
 
Table 3. Extended description of the chromatographic conditions employed by several authors for the analysis of STLs using HPLC.  
Column Mobile phase Gradient mode 
Flow rate 
(ml/min) 
Injection 
volume (µL) 
HPLC equipment 
λ 
(nm) 
T 
(⁰C) 
Analyte 
structure 
Retention 
time (min) 
Reference 
Analytical separation 
C18 (10 µm; 
200x4.0 mm) 
MeOH/H2O 
(30:70) 
- 0.8 10 
410 LC quaternary pump 
(Perkin Elmer); LCJ 90 UV 
detector (Perkin Elmer) 
230 - 8,9 
1: 7.3 
2: 6.7 
(Fardella et 
al. 1999) 
C18 (5 µm; 
250x3.0 mm) 
A: MeOH/H2O 
14/86 (v/v) 
B: MeOH/H2O 
64/36 (v/v) 
t = 0 - 20 min, 100–
58% A; t = 20 - 30 
min, 58% A; t = 30 - 
45 min, 58–0% A; t = 
45 - 50 min, 0% A; t = 
50 - 52 min, 0–100% 
A; t = 52 - 62 min, 
100% A (postrun) 
0.5 20 
Jasco; 2 binary pumps 
(mod.PU-1580); 
Autosampler (mod. AS-
2055 Plus); DAD detector 
(mod. MD-1510, quartz 
flow cell, 10 mm optical 
path) 
260 25 10 17.7 
(Ferioli & 
D’Antuono 
2012) 
C18 (5 µm; 
250x4.6 mm) 
A: IPA/MeCN/ 
MeOH/ H2O, 
0.3% HCOOH 
18:30:12:40 
(v/v) 
B: H2O, 0.3% 
HCOOH 
t = 0 – 35min,  8-48% 
A 
1.0 20 
HP 1100 HPLC system; 
Quaternary pump G1311A; 
UV/DAD detector G 1315A 
254 25 11 37.0 
(Fritsche et 
al. 2002) 
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C18 (5µm; 
250×4.6 mm) 
MeCN/H2O 
(55:45) 
- 1.0 10 
Agilent 1200 system; 
Quaternary solvent 
delivery system; Auto-
sampler; DAD detector 
210 40 12 ca. 16.5 
(Huo et al. 
2010) 
C18 (5 µm; 
250x4.6 mm) 
A: H2O, 0.1% 
H3PO4 
B: 90% MeCN, 
10% H2O 
t = 0 – 60 min, 99:1 
(A:B) - 48:52 (A:B) 
1.0 15 DAD detector 200 35 13 15.8 
(Sessa et al. 
2000) 
C18 (5 µm; 
250x4.0 mm) 
MeOH/H2O 
(50:50) 
- 1.0 - 
Sykam S-1000; Shimadzu 
SPD-M10A DAD detector 
225/ 
265 
- 14 13.6 
(Spring et al. 
2003) 
C18 (5 µm; 
250×4.6 mm) 
MeOH/H2O 
(70:30) 
- - 20 
Beckman GOLD series; 
Dual solvent pump (model 
125 solvent module); DAD 
detector (mod. 168) 
225 
T 
room 
15 9.5 
(Zhang et al. 
2011) 
Semi-preparative separation 
C18 (6 µm; 
300×7.8mm) 
MeOH/H2O 
(47:53) 
- 
1.0 10 
Agilent 1200 system; 
Quaternary solvent 
delivery system; Auto-
sampler; DAD detector 
210 40 
16 ca. 20.5 
(Huo et al. 
2010) 
MeOH/H2O 
(52:48) 
- 17 ca. 21.0 
C18 (250 
x21.2 mm) 
A: H2O 
B: MeCN 
t = 0–44 min, 10–100% 
B 
10 1000 
Shimadzu SLC-10 Avp; SPD 
10 Avp DAD detector 
- - 18 30.0 
(Igual et al. 
2013) 
C18 (5 µm; 
250×30.0 
mm) 
MeOH/H2O 
(70:30) 
- - - 
Agilent-1100 MWD; 
Shimadzu UV - 2401PC 
detector 
-
- 
-
- 
19 - 
(Liao et al. 
2012) 
C18 (10 μm; 
250x10 mm) 
MeOH/H2O - 1.5 - 
Beckman Coulter Gold-168 
system; DAD detector 
- - 20 96.0 
(Youn et al. 
2014) 
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A.2. Structures of sesquiterpene lactones analyzed by HPLC by 
several authors 
 
 
Figure 15. Chemical structures of sesquiterpene lactones analyzed by HPLC under the conditions of Table 2. 
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A.3. Gradient mode programs for the chromatographic separation of 
compounds 6 and 7. 
 
 
Figure 16. Different gradient mode compositions, using H2O (A)/ MeOH or MeCN (B) as the mobile 
phase, employed for the HPLC analysis of STLs 6 and 7. 
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A.4. Amplifications of HSQC, COSY and HMBC spectra of compound 7 
 
Figure 17. 2D NMR–HSQC spectrum (CDCl3), for compound 7, with amplifications between 1-3.5 ppm (
1
H) and 18-
56 ppm (
13
C). 
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Figure 18. 2D NMR–COSY spectrum (CDCl3), for compound 7, with amplifications between 1-6 ppm (
1
H). 
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Figure 19. 2D NMR–HMBC spectrum (CDCl3), for compound 7, with amplifications between 1-6.6 ppm (
1
H) and 
105-185 ppm (
13
C). 
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A.5. Data retrieved from the spectra of 1H NMR and 13C NMR 
 
Table 4. NMR data of compounds 6 and 6a. 
a 
 6 b 6a c 
Position δ (1H) δ (13C) δ (1H) δ (13C) 
1 3.22 dd broad (8.0, 8.1) 40.94 3.14 ddd (8.7, 4.8, 2.2) 39.60 
2α 2.48 dd (11.8, 7.4) 42.70 2.31-2.37 m 47.46 
2β 2.51 dd (11.8, 8.4) - 2.51-2.58 m - 
3 - 218.32 - 217.80 
4 2.44 q broad (9.7, 7.2) 46.96 2.53 q (7.7) 43.38 
5 2.27-2.36 m 51.78 2.27-2.35 m 50.95 
6 4.08 dd (9.7, 9.3) 80.81 4.05 t (9.7) 83.32 
7 3.31 dt ( 9.9, 3.3) 46.88 2.65-2.67 m 44.94 
8 5.13 ddd (9.9, 6.3, 5.7) 76.01 3.63 ddd (13.2, 9.6, 5.7) 73.91 
9α 2.32 dd (13.6, 6.3) 41.11 2.19 dd (12.4, 9.6) 47.22 
9β 2.88 dd (13.6, 5.7) - 2.87 dd (12.4, 5.7) - 
10 - 141.59 - 144.13 
11 - 135.65 2.51-2.58 m 38.64 
12 - 169.12 - 174.99 
13α 6.33 d (3.6) 125.74 2.27-2.35 m 54.53 
13β 6.11 d (3.2) - 2.27-2.35 m - 
14α 4.97 s 117.77 4.78 s 114.78 
14β 5.1 s - 5.08 s - 
15 1.26 d (7.3) 15.51 1.23 d (7.7) 14.54 
N(CH3)2 - - 2.65 s 34.85 
1' - 175.15 - 175.18 
2' - 76.12 - 73.91 
3’α 3.88 d (11.6) 67.98 2.93 dd (12.9, 2.3) 59.17 
3’β 3.65 d (11.6) - 2.56 dd (12.9, 1.5) - 
4' 1.39 s 22.33 2.03 s 20.79 
a δ (ppm) and J (Hz), when resolved, indicated in parentheses; Data were obtained in CDCl3; s singlet, d  
doublet, m multiplet, t triplet, q quartet, dd double doublet, ddd   double doublet, dt double triplet; b obtained  
in the Bruker Avance III - 400 NMR; c obtained in the Bruker ASCEND - 700 NMR. 
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Table 5. NMR data of compounds 7 and 7a. 
a 
 7 b 7a c 
Position δ (1H) δ (13C) δ (1H) δ (13C) 
1 2.96 ddd (12.0, 8.2, 7.7) 45.71 2.92 dd broad (8.8, 7.6) 43.85 
2α 2.18 dd broad (12.8, 7.6) 39.22 2.31 ddd (13.4, 7.4, 7.6) 38.57 
2β 1.73 ddd (12.8/12.0/7.6 - 1.74 ddd (13.4, 8.8, 2.0) - 
3 4.54 t broad (7.6) 73.75 4.53 dt (7.4, 2.0) 73.68 
4 - 152.16 - 152.61 
5 2.78 dd (9.5, 8.2) 52 2.85-2.89 m 49.65 
6 4.28 dd (9.5, 9.2) 78.22 4.10 t (9.9) 79.14 
7 3.12 dt (9.2, 3.2) 47.09 2.68 ddd (11.4, 9.9, 2.6) 45.48 
8 5.09 m 75.79 3.59-3.62 m 73.27 
9α 2.67 dd (13.8, 3.9) 35.98 2.72 dd (13.1, 4.7) 43.23 
9β 2.37 d broad (13.8) - 2.20 dd (13.1, 7.7) - 
10 - 141.81 - 143.35 
11 - 137.04 2.33-2.37 m 45.48 
12 - 169.48 - 175.14 
13α 6.20 d (3.6) 123.81 2.09 d broad (9.7) 57.77 
13β 5.95 d (3.2) - 2.06 d broad (9.7) - 
14α 4.85 s 118.43 5.04 s 116.07 
14β 5.12 s - 5.06 s - 
15 α 5.35 s 114.24 5.34 s 112.70 
15β 5.46 s - 5.39 s - 
N(CH3)2 - - 2.66 s 34.84 
1' - 175.24 - 175.29 
2' - 76.2 - 73.68 
3’α 3.82 d (11.6) 68.23 2.85-2.89 m 59.42 
3’β 3.62 d (11.6) - 2.55 d (12.4) - 
4' 1.38 s 22.09 2.04 s 20.80 
a δ (ppm) and J (Hz), when resolved, indicated in parentheses; Data were obtained in CDCl3; s singlet, d  
doublet, m multiplet, t triplet, q quartet, dd double doublet, ddd   double doublet, dt double triplet; b obtained  
in the Bruker Avance III - 400 NMR; c obtained in the Bruker ASCEND - 700 NMR. 
 
